BNET Industries
NeuroMetrix (NURO) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $44.6M
- Profit
- Dec 31 2007
- ($8.3M)
- Market Cap
- Sep 04 2008
- $15.4M
Latest News and Analysis
NeuroMetrix: Revenues Decline, Prospects Look Bleak
Douglas Cress submits: NeuroMetrix NURO reported quarterly revenues of $8.5 million on Tuesday, down approximately 26% from the same period in 2007. The company generated a scant $510,000 (or 6% or revenues) from the sale of devices, including NC-stat System and the newer Advance. That could spell trouble for future...
Additional Resources
NeuroMetrix, Inc. Reports Total Revenues of $8.5 Million for the Second Quarter of 2008
- Decrease of 26% from the second quarter of 2007 - Cash and investment position of $22.8 Million - Commercial launch of ADVANCE[TM] System to neurologists and other specialists - Medical equipment sales focused on specialist physicians with peripheral nerve expertise WALTHAM,...
NeuroMetrix completes CE Technical File and Achieves CE Marking for its ADVANCE™ System allowing Marketing in the European Union
WALTHAM, Mass. -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has completed the CE technical file for its ADVANCE System ("ADVANCE"). With this regulatory step, NeuroMetrix intends to begin marketing ADVANCE to neurologists, clinical neurophysiologists, hand surgeons, and other specialists in the EU. ADVANCE is a comprehensive...
Now In Its Fourth Year, 'The CNS Market 2008 Report' Is an Expanded and Updated 400 Page Report of Brain and Nervous System Markets and Treatments
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/ab0827/the_cns_market_200) has announced the addition of the "The CNS Market 2008 Report" published by NeuroInsights to their offering. Drugs, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease...
NeuroMetrix Announces Initial Sales of ADVANCE™ System for the Performance of Nerve Conduction Studies and Needle Electromyography Procedures to Neurologists and Other Specialists
WALTHAM, Mass. -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it recently completed the initial sales of its ADVANCE System ("ADVANCE"). The device, which recently received 510k clearance from the U.S. Food and Drug Administration FDA, is a comprehensive platform for the performance of traditional nerve conduction...
NeuroMetrix, Inc. Implements Cost Reduction Program
WALTHAM, Mass. -- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company advancing patient care through the development and marketing of innovative medical device products that aid physicians in the diagnosis and treatment of diseases of the nervous system and neurovascular disorders and that provide regional anesthesia and pain control, announced...
Brower Piven Informs Investors That They Have Only Until May 16, 2008 to Move for Appointment as Lead Plaintiff in NeuroMetrix, Inc. Class Action Lawsuit
Brower Piven, A Professional Corporationannounces that shareholders of NeuroMetrix, Inc. (NASDAQ: NURO)("NeuroMetrix" or the "Company") who purchased shares of NeuroMetrixbetween October 27, 2005 and March 6, 2007, inclusive (the "Class Period")have only until May 16, 2008 to move for appointment as Lead Plaintiff in asecurities class action lawsuit currently pending...
NeuroMetrix, Inc. Reports Total Revenues of $9.1 Million for the First Quarter of 2008, Decrease of 23% from the First Quarter of 2007; Cash and Investment Position of $26.6 Million
WALTHAM, Mass. -- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company advancing patient care through the development and marketing of innovative medical device products that aid physicians in the diagnosis and treatment of diseases of the nervous system and neurovascular disorders and that provide regional anesthesia and pain control, announced...
NeuroMetrix Announces Executive Management Change
Gary L. Gregory Resigns as Chief Operating Officer Effective May 31, 2008 WALTHAM, Mass. -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Gary L. Gregory, the company's Chief Operating Officer, will be leaving the company to pursue new professional opportunities. Mr. Gregory's resignation will become effective May 31,...
NeuroMetrix, Inc. Announces Date for 2008 First Quarter Financial Results Conference Call
WALTHAM, Mass. -- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2008 first quarter financial results before the opening of the market on Tuesday, May 6, 2008. The Company's management team will host a conference call and webcast at 10:00 A.M. Eastern time, on the same day,...
NeuroMetrix Receives FDA 510 Clearance for the ADVANCE™ System for the Performance of Nerve Conduction Studies and Needle Electromyography Procedures
WALTHAM, Mass. -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has received 510k clearance for its ADVANCE System ("ADVANCE") from the U.S. Food and Drug Administration FDA. This regulatory determination by the FDA gives NeuroMetrix clearance to market ADVANCE in the U.S. market. The device is intended to be...
NPSP, NURO, PCYC, STEN, TONE, ATNO Have Also Been Removed From Naked Short List Today.
M2 PRESSWIRE-31 March 2008-BUYINS.NET: NPSP, NURO, PCYC, STEN, TONE, ATNO Have Also Been Removed From Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:31032008 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and...
Holzer Holzer & Fistel, LLC Announces Shareholder Class Action Has Been Filed Against NeuroMetrix Inc.
A shareholder class action lawsuit has beenfiled in the United States District Court for the District of Massachusettsagainst NeuroMetrix, Inc. ("NeuroMetrix" or the "Company") (NASDAQ: NURO)and various individuals on behalf of purchasers of the Company's commonstock who purchased stock between October 27, 2005 and March 6, 2007 (the"Relevant Period"). ...
Brower Piven Announces the Filing of a Class Action Lawsuit Against NeuroMetrix Inc.
Brower Piven, A Professional Corporationannounces that a class action lawsuit has been commenced in the UnitedStates District Court for the District of Massachusetts on behalf ofpurchasers of the common stock of NeuroMetrix Inc. ("NeuroMetrix" or the"Company") (NASDAQ: NURO) between October 27, 2005 and March 6, 2007,inclusive (the "Class Period"). The...
Pittsburgh Law Office of Alfred G. Yates Jr., PC Commences a Class Action Lawsuit On Behalf of Shareholders of SunOpta Inc. and Announces Investigations of MF Global , Force Protection , The PMI Group , and NeuroMetrix
PITTSBURGH -- Notice is hereby given by the Law Office of Alfred G. Yates Jr., PC that a class action has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of SunOpta Inc. (NASDAQ: STKL) ("SunOpta" or the "Company") between...
NeuroMetrix Says Securities Class Action Lawsuit Without Merit
WALTHAM, Mass. -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it and certain of its officers were named as defendants in a purported securities class action lawsuit filed in the United States District Court for the District of Massachusetts. The lawsuit alleges, among other things, that the defendants made false...
Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Neurometrix Inc
NEW YORK -- Coughlin Stoia Geller Rudman & Robbins LLP ("Coughlin Stoia") (http://www.csgrr.com/cases/neurometrix/) today announced that a class action has been commenced in the United States District Court for the District of Massachusetts on behalf of purchasers of NeuroMetrix Inc. ("NeuroMetrix") (NASDAQ:NURO) common stock during the period between October 27,...
CHRT, CLWR, NGPC, NURO, RACK, REED Have Also Been Added To Naked Short List Today.
M2 PRESSWIRE-14 March 2008-BUYINS.NET: CHRT, CLWR, NGPC, NURO, RACK, REED Have Also Been Added To Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:14032008 BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and...
NSTR, NURO, PHHM, TSEM, SHSN, LKRV Have Also Been Removed From Naked Short List Today.
M2 PRESSWIRE-27 February 2008-BUYINS.NET: NSTR, NURO, PHHM, TSEM, SHSN, LKRV Have Also Been Removed From Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:27022008 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and...
TMA, NEP, MBRK, NURO, VEXP, CBPC Have Been On BUYINS.NET Naked Short List For 13 Consecutive Trading Days.
M2 PRESSWIRE-22 February 2008-BUYINS.NET: TMA, NEP, MBRK, NURO, VEXP, CBPC Have Been On BUYINS.NET Naked Short List For 13 Consecutive Trading DaysC1994-2008 M2 COMMUNICATIONS LTD RDATE:22022008 BUYINS.NET, www.buyins.net, announced today that these select companies have been on the NASDAQ,...
- Next »
- page 1 of 1
- « Previous
Sort byClose
- Incorporated: 1996
- CEO: Dr. Shai N. Gozani Ph.D.
NeuroMetrix is engaged in the design, development and selling of proprietary medical devices designed to help physicians to diagnose neuropathies and neurovascular disease. As of Dec 31 2006, Co.'s neuropathy diagnostic system, the NC-stat System, comprised of disposable single use biosensors; NC-stat device and related components; and NC-stat docking station, an optional device that enables the physician to transmit data to Co.'s onCall information system. Co. also offers DigiScopeŽ, which allows primary care physicians and endocrinologists to diagnose diabetic retinopathy and refer patients to the ophthalmologist for treatment if deemed necessary based on the results.
Key Competitors
NeuroMetrix Company Info
Board of Directors
Dr. Shai N. Gozani Ph.D.
Chairman
Dr. David E. Goodman M.D.
Dr. Allen J. Hinkle M.D.
Mr. Charles R. LaMantia
Mr. W. Mark Lortz
Contact Information
62 Fourth Avenue
Waltham, MA
781 890-9989